FDA warns seniors to avoid this vaccine after deadly complications

Older adults are being warned against receiving the chikungunya vaccine before traveling.

The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) in November 2023 as the first of its kind.

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus.

FIRST VACCINE FOR CHIKUNGUNYA VIRUS, AN ‘EMERGING GLOBAL HEALTH THREAT,’ GETS FDA APPROVAL

But the...